Arkfeld Wealth Strategies, L.L.C. Amarin Corp Plcuk Transaction History
Arkfeld Wealth Strategies, L.L.C.
- $233 Million
- Q1 2025
A detailed history of Arkfeld Wealth Strategies, L.L.C. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Arkfeld Wealth Strategies, L.L.C. holds 58,000 shares of AMRN stock, worth $773,140. This represents 0.01% of its overall portfolio holdings.
Number of Shares
58,000
Previous 58,000
-0.0%
Holding current value
$773,140
Previous $27,000
7.41%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AMRN
# of Institutions
154Shares Held
70.1MCall Options Held
133KPut Options Held
26.4K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$331 Million60.8% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$165 Million9.37% of portfolio
-
Acadian Asset Management LLC Boston, MA3.79MShares$50.5 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY3.4MShares$45.3 Million3.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$35 Million0.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $5.37B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...